You have selected the view in English
| Descriptor English: | Pipobroman | ||||||
| Descriptor Spanish: |
Pipobromán
| ||||||
| Descriptor Portuguese: | Pipobromano | ||||||
| Descriptor French: | Pipobroman | ||||||
| Entry term(s): |
Vercyte |
||||||
| Tree number(s): |
D03.383.606.773 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010885 | ||||||
| Scope note: | An antineoplastic agent that acts by alkylation. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Antineoplastic Agents, Alkylating |
||||||
| Registry Number: | 6Q99RDT97R | ||||||
| CAS Type 1 Name: | Piperazine, 1,4-bis(3-bromo-1-oxopropyl)- | ||||||
| Previous Indexing: |
Antineoplastic Agents (1966) Bromine (1966) Piperazines (1966) Propionates (1966) |
||||||
| Public MeSH Note: | 73 |
||||||
| History Note: | 73(67) |
||||||
| DeCS ID: | 11318 | ||||||
| Unique ID: | D010885 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1973/01/01 | ||||||
| Date of Entry: | 1999/01/01 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Pipobroman
- Preferred
Vercyte
- Narrower
| Concept UI |
M0016890 |
| Scope note | An antineoplastic agent that acts by alkylation. |
| Preferred term | Pipobroman |
| Concept UI |
M0474849 |
| Preferred term | Vercyte |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
